Amnion

• 

  Subject Areas on Research

  • Amniotic membrane use for management of corneal limbal stem cell deficiency. 
  • Bacteria localization and chorion thinning among preterm premature rupture of membranes. 
  • Bacterial colonization of amniotic fluid from intact fetal membranes. 
  • Bacterial colonization of amniotic fluid in the presence of ruptured membranes. 
  • Characterization and comparison of commercially available antinuclear antibody kits using single pattern index sera. 
  • Continuous prostaglandin-F 2 infusion for middle-trimester abortion. 
  • Cryopreserved human amniotic membrane injection for plantar fasciitis: a randomized, controlled, double-blind pilot study. 
  • Dehydrated Allogenic Human Amniotic Membrane Graft for Conjunctival Surface Reconstruction Following Removal of Exposed Scleral Buckle. 
  • Double occupancy. 
  • Expression of c-fos in parietal endoderm, amnion and differentiating F9 teratocarcinoma cells. 
  • Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila tolloid. 
  • Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction. 
  • In vivo downregulation of innate and adaptive immune responses in corneal allograft rejection by HC-HA/PTX3 complex purified from amniotic membrane. 
  • Infection-induced thrombin production: a potential novel mechanism for preterm premature rupture of membranes (PPROM). 
  • Inflammatory Response of Human Gestational Membranes to Ureaplasma parvum Using a Novel Dual-Chamber Tissue Explant System. 
  • Modified simple limbal epithelial transplantation using cryopreserved amniotic membrane for unilateral limbal stem cell deficiency. 
  • PROLONGED RUPTURE OF FETAL MEMBRANES. 
  • Prenatal diagnosis of Sanfilippo syndrome type A by early amniocentesis. 
  • Progesterone receptor membrane component 1 (PGRMC1) expression in fetal membranes among women with preterm premature rupture of the membranes (PPROM). 
  • Progestins Inhibit Tumor Necrosis Factor α-Induced Matrix Metalloproteinase 9 Activity via the Glucocorticoid Receptor in Primary Amnion Epithelial Cells. 
  • Progressive Cactus is a multiple-genome aligner for the thousand-genome era. 
  • Quantifying dorsal closure in three dimensions. 
  • The Effect of Progestins on Tumor Necrosis Factor α-Induced Matrix Metalloproteinase-9 Activity and Gene Expression in Human Primary Amnion and Chorion Cells In Vitro. 
  • The case for careful examination of the placenta. Helpful information from the delivery room. 
  • Transforming growth factor-beta inhibits prostaglandin production in amnion and A431 cells. 
  • Trisomy 8 mosaicism: selective growth advantage of normal cells vs. growth disadvantage of trisomy 8 cells. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology